[Beta-adrenergic antagonists and endoscopic sclerotherapy for the prevention of digestive hemorrhage].
Lebrec
D
D
Unité de Recherches de Physiopathologie Hépatique (INSERM U-24), Hôpital Beaujon, Clichy.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D016099:Endoscopy, Gastrointestinal / Q000379:methods; D006471:Gastrointestinal Hemorrhage / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D006975:Hypertension, Portal / Q000150:complications*; D011433:Propranolol / Q000627:therapeutic use; D012597:Sclerosing Solutions / Q000627:therapeutic use; D015911:Sclerotherapy / Q000379:methods*
D000319:Adrenergic beta-Antagonists; D012597:Sclerosing Solutions; D011433:Propranolol
Antagonistes beta-adrénergiques et scléroses endoscopiques pour la prévention des hémorragies digestives.